Published in Proc Natl Acad Sci U S A on January 03, 2005
p53 activation by knockdown technologies. PLoS Genet (2007) 6.85
MicroRNA-125b is a novel negative regulator of p53. Genes Dev (2009) 4.43
Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev (2007) 3.45
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell (2008) 3.15
p53 isoform delta113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafish. Genes Dev (2009) 2.57
Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafish. Genes Dev (2005) 2.44
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proc Natl Acad Sci U S A (2005) 2.19
Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2005) 2.07
Hooked! Modeling human disease in zebrafish. J Clin Invest (2012) 2.00
Zebrafish cancer: the state of the art and the path forward. Nat Rev Cancer (2013) 1.87
Reverse genetics in zebrafish by TILLING. Brief Funct Genomic Proteomic (2008) 1.73
Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc Natl Acad Sci U S A (2007) 1.70
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer. EMBO J (2015) 1.69
Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A (2008) 1.63
Telomerase is required for zebrafish lifespan. PLoS Genet (2013) 1.59
The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol (2013) 1.54
UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell (2014) 1.50
The zebra fish cassiopeia mutant reveals that SIL is required for mitotic spindle organization. Mol Cell Biol (2007) 1.47
Poised Regeneration of Zebrafish Melanocytes Involves Direct Differentiation and Concurrent Replenishment of Tissue-Resident Progenitor Cells. Dev Cell (2015) 1.38
p53 ancestry: gazing through an evolutionary lens. Nat Rev Cancer (2009) 1.37
Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish. Oncogene (2008) 1.36
Loss of ribosomal protein L11 affects zebrafish embryonic development through a p53-dependent apoptotic response. PLoS One (2009) 1.36
Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep (2006) 1.33
Generation of medaka gene knockout models by target-selected mutagenesis. Genome Biol (2006) 1.30
Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish. PLoS One (2010) 1.30
FishNet: an online database of zebrafish anatomy. BMC Biol (2007) 1.27
The zebrafish as a model for cancer. Dis Model Mech (2010) 1.25
Malignant peripheral nerve sheath tumors. Oncologist (2014) 1.23
Ribosomal biogenesis genes play an essential and p53-independent role in zebrafish pancreas development. Development (2012) 1.22
Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis. Dev Cell (2010) 1.22
Morpholino artifacts provide pitfalls and reveal a novel role for pro-apoptotic genes in hindbrain boundary development. Dev Biol (2010) 1.22
Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish. PLoS Genet (2011) 1.22
Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish. Blood (2010) 1.20
Mutation of the zebrafish nucleoporin elys sensitizes tissue progenitors to replication stress. PLoS Genet (2008) 1.19
In vivo analysis of choroid plexus morphogenesis in zebrafish. PLoS One (2008) 1.18
The primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway. Hum Mol Genet (2008) 1.18
Sex reversal in zebrafish fancl mutants is caused by Tp53-mediated germ cell apoptosis. PLoS Genet (2010) 1.18
Using retroviruses as a mutagenesis tool to explore the zebrafish genome. Brief Funct Genomic Proteomic (2008) 1.15
Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-γ and p53 signaling. Nat Chem Biol (2012) 1.15
Transient knockdown and overexpression reveal a developmental role for the zebrafish enosf1b gene. Cell Biosci (2011) 1.14
A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish. Dis Model Mech (2011) 1.13
p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage. Cell Res (2015) 1.11
Hematopoietic defects in rps29 mutant zebrafish depend upon p53 activation. Exp Hematol (2011) 1.11
A non-canonical function of zebrafish telomerase reverse transcriptase is required for developmental hematopoiesis. PLoS One (2008) 1.08
Live imaging of apoptotic cells in zebrafish. FASEB J (2010) 1.07
PCB126 exposure disrupts zebrafish ventricular and branchial but not early neural crest development. Toxicol Sci (2008) 1.07
p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J (2011) 1.07
Generation of clonal zebrafish lines and transplantable hepatic tumors. Nat Protoc (2010) 1.06
Bax, Bcl2, and p53 differentially regulate neomycin- and gentamicin-induced hair cell death in the zebrafish lateral line. J Assoc Res Otolaryngol (2013) 1.05
Genetic and environmental melanoma models in fish. Pigment Cell Melanoma Res (2010) 1.04
Oligodendrocyte progenitor cell numbers and migration are regulated by the zebrafish orthologs of the NF1 tumor suppressor gene. Hum Mol Genet (2010) 1.04
A zebrafish model of Roberts syndrome reveals that Esco2 depletion interferes with development by disrupting the cell cycle. PLoS One (2011) 1.03
The Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine. Genes Cancer (2011) 1.02
Identification of a heritable model of testicular germ cell tumor in the zebrafish. Zebrafish (2009) 1.02
Premature aging in telomerase-deficient zebrafish. Dis Model Mech (2013) 1.01
Aberrant AKT activation drives well-differentiated liposarcoma. Proc Natl Acad Sci U S A (2011) 1.00
Def defines a conserved nucleolar pathway that leads p53 to proteasome-independent degradation. Cell Res (2013) 1.00
Neoplasia and neoplasm-associated lesions in laboratory colonies of zebrafish emphasizing key influences of diet and aquaculture system design. ILAR J (2012) 0.99
Emi1 maintains genomic integrity during zebrafish embryogenesis and cooperates with p53 in tumor suppression. Mol Cell Biol (2009) 0.97
Highly aneuploid zebrafish malignant peripheral nerve sheath tumors have genetic alterations similar to human cancers. Proc Natl Acad Sci U S A (2010) 0.96
Zebrafish Hagoromo mutants up-regulate fgf8 postembryonically and develop neuroblastoma. Mol Cancer Res (2009) 0.96
Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood (2011) 0.95
Genetic modeling of Li-Fraumeni syndrome in zebrafish. Dis Model Mech (2010) 0.95
Autophagy induction is a Tor- and Tp53-independent cell survival response in a zebrafish model of disrupted ribosome biogenesis. PLoS Genet (2013) 0.94
A network of epigenetic regulators guides developmental haematopoiesis in vivo. Nat Cell Biol (2013) 0.94
Zebrafish models of cancer: progress and future challenges. Curr Opin Genet Dev (2013) 0.94
Loss of Llgl1 in retinal neuroepithelia reveals links between apical domain size, Notch activity and neurogenesis. Development (2012) 0.94
Nuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryos. Mol Cancer Ther (2009) 0.93
p53 and TAp63 promote keratinocyte proliferation and differentiation in breeding tubercles of the zebrafish. PLoS Genet (2014) 0.93
Neocuproine ablates melanocytes in adult zebrafish. Zebrafish (2008) 0.93
Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing. PLoS One (2012) 0.92
brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis. Proc Natl Acad Sci U S A (2010) 0.91
The Cdc14B phosphatase contributes to ciliogenesis in zebrafish. Development (2011) 0.91
Gpr125 modulates Dishevelled distribution and planar cell polarity signaling. Development (2013) 0.91
Cyclin-dependent kinase inhibitor p20 controls circadian cell-cycle timing. Proc Natl Acad Sci U S A (2013) 0.91
Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos. BMC Dev Biol (2010) 0.91
Autophagy is essential for cardiac morphogenesis during vertebrate development. Autophagy (2014) 0.90
Nephronophthisis-associated CEP164 regulates cell cycle progression, apoptosis and epithelial-to-mesenchymal transition. PLoS Genet (2014) 0.90
The caveolin-cavin system plays a conserved and critical role in mechanoprotection of skeletal muscle. J Cell Biol (2015) 0.90
Ccdc94 protects cells from ionizing radiation by inhibiting the expression of p53. PLoS Genet (2012) 0.90
A morpholino-based screen to identify novel genes involved in craniofacial morphogenesis. Dev Dyn (2013) 0.90
H. pylori virulence factor CagA increases intestinal cell proliferation by Wnt pathway activation in a transgenic zebrafish model. Dis Model Mech (2013) 0.90
A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis. Dis Model Mech (2011) 0.90
p63 mediates an apoptotic response to pharmacological and disease-related ER stress in the developing epidermis. Dev Cell (2011) 0.89
cpsf1 is required for definitive HSC survival in zebrafish. Blood (2011) 0.89
Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models. PLoS Genet (2013) 0.88
Vgll2a is required for neural crest cell survival during zebrafish craniofacial development. Dev Biol (2011) 0.88
TNF receptors regulate vascular homeostasis in zebrafish through a caspase-8, caspase-2 and P53 apoptotic program that bypasses caspase-3. Dis Model Mech (2012) 0.88
Zebrafish models of p53 functions. Cold Spring Harb Perspect Biol (2010) 0.88
The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia. Dis Model Mech (2014) 0.88
Ribosomal protein mutations induce autophagy through S6 kinase inhibition of the insulin pathway. PLoS Genet (2014) 0.88
Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. Dis Model Mech (2012) 0.88
Fluorescent imaging of cancer in zebrafish. Methods Cell Biol (2011) 0.87
Identification and expression of the family of classical protein-tyrosine phosphatases in zebrafish. PLoS One (2010) 0.87
Mutations in LRRC50 predispose zebrafish and humans to seminomas. PLoS Genet (2013) 0.87
Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish. PLoS One (2013) 0.87
Alkylation damage causes MMR-dependent chromosomal instability in vertebrate embryos. Nucleic Acids Res (2008) 0.86
Loss of function of myosin chaperones triggers Hsf1-mediated transcriptional response in skeletal muscle cells. Genome Biol (2015) 0.86
L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way. Br J Haematol (2014) 0.86
Surfing the p53 network. Nature (2000) 35.36
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60
Participation of p53 protein in the cellular response to DNA damage. Cancer Res (1991) 16.00
Live or let die: the cell's response to p53. Nat Rev Cancer (2002) 15.06
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science (1994) 13.51
The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat (2002) 12.39
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell (1995) 12.39
Signaling to p53: breaking the MDM2-p53 circuit. Cell (1998) 8.63
Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev (2003) 8.00
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (1993) 7.90
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (1991) 7.49
p53: death star. Cell (2000) 4.77
Control of apoptosis by p53. Oncogene (2003) 4.46
Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol (2004) 3.99
Drosophila p53 binds a damage response element at the reaper locus. Cell (2000) 3.92
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet (2003) 3.61
Headwaters of the zebrafish -- emergence of a new model vertebrate. Nat Rev Genet (2002) 3.56
Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res (2000) 3.50
Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell (2000) 3.41
Mouse models of tumor development in neurofibromatosis type 1. Science (1999) 3.40
A subset of p53-deficient embryos exhibit exencephaly. Nat Genet (1995) 3.24
Regulation of p53 in response to DNA damage. Oncogene (1999) 3.23
Caenorhabditis elegans p53: role in apoptosis, meiosis, and stress resistance. Science (2001) 3.16
Myc-induced T cell leukemia in transgenic zebrafish. Science (2003) 3.15
Rescuing the function of mutant p53. Nat Rev Cancer (2001) 2.95
Mouse tumor model for neurofibromatosis type 1. Science (1999) 2.89
The UMD-p53 database: new mutations and analysis tools. Hum Mutat (2003) 2.89
Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol (2001) 2.77
Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr Biol (2002) 2.76
Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67
Soft tissue sarcomas. Curr Probl Surg (1996) 2.62
Target-selected inactivation of the zebrafish rag1 gene. Science (2002) 2.60
Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol (2004) 2.57
High-frequency developmental abnormalities in p53-deficient mice. Curr Biol (1995) 2.57
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A (1990) 2.52
Apoptosis in the developing zebrafish embryo. Dev Biol (2001) 2.16
Zebrafish as a cancer model system. Cancer Cell (2002) 2.12
From Zebrafish to human: modular medical models. Annu Rev Genomics Hum Genet (2002) 2.07
Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc Natl Acad Sci U S A (2000) 2.04
The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci (1999) 1.68
Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol (1999) 1.52
To die or not to die: how does p53 decide? Oncogene (2004) 1.45
Zebrafish: a new model on the pharmaceutical catwalk. Bioessays (2003) 1.44
Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours. Virchows Arch (1995) 1.39
Regulation of mutant p53 temperature-sensitive DNA binding. J Biol Chem (1996) 1.34
Zebrafish: a new model for human disease. Genome Res (1999) 1.31
Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer (1998) 1.27
Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library. J Biol Chem (2003) 1.16
Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies. Proc Natl Acad Sci U S A (2002) 1.08
CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations. Am J Pathol (1998) 1.03
Zebrafish (Danio rerio) p53 tumor suppressor gene: cDNA sequence and expression during embryogenesis. Mol Mar Biol Biotechnol (1997) 1.01
The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells. Blood (1998) 1.00
Apoptosis in zebrafish development. Comp Biochem Physiol B Biochem Mol Biol (2003) 0.95
Zebrafish myelopoiesis and blood cell development. Curr Opin Hematol (2001) 0.92
Zebrafish as a model organism for blood diseases. Br J Haematol (2003) 0.88
A new human malignant peripheral nerve sheath tumour-cell line, HS-sch-2, harbouring p53 point mutation. Int J Oncol (2000) 0.84
Functional characterization of Xenopus laevis p53: evidence of temperature-sensitive transactivation but not of repression. J Virol (1994) 0.82
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med (2002) 24.88
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med (2002) 14.01
Phylogenetic shadowing and computational identification of human microRNA genes. Cell (2005) 13.24
Regulation of the germinal center response by microRNA-155. Science (2007) 12.25
Hematopoiesis: an evolving paradigm for stem cell biology. Cell (2008) 11.95
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol (2003) 11.33
PDGFRA activating mutations in gastrointestinal stromal tumors. Science (2003) 11.11
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood (2004) 11.07
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med (2011) 11.07
Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med (2011) 9.90
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24
The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn (2007) 8.86
Acute lymphoblastic leukaemia. Lancet (2008) 8.54
The zebrafish reference genome sequence and its relationship to the human genome. Nature (2013) 8.52
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell (2005) 7.99
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature (2007) 7.55
Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature (2008) 6.80
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A (2006) 6.80
In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods (2006) 6.67
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell (2002) 6.64
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol (2008) 6.43
Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12
Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol (2007) 6.11
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol (2008) 6.11
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med (2003) 6.07
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol (2006) 6.00
Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol (2003) 5.73
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature (2007) 5.65
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature (2009) 5.55
The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab (2005) 5.32
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A (2007) 5.24
H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell (2008) 5.23
Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res (2006) 5.23
Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell (2008) 5.09
Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science (2012) 4.92
Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med (2005) 4.92
Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell (2009) 4.69
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med (2007) 4.59
Concern Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res (2004) 4.50
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet (2004) 4.45
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A (2008) 4.43
The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science (2010) 4.37
53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat Immunol (2004) 4.14
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J Clin Oncol (2008) 4.10
Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol (2003) 4.07
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell (2012) 4.04
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol (2010) 4.01
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer (2006) 3.89
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. Blood (2004) 3.84
Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell (2011) 3.81
Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell (2005) 3.73
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol (2005) 3.68
Genetic analysis of cavefish reveals molecular convergence in the evolution of albinism. Nat Genet (2005) 3.66
Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat Cell Biol (2010) 3.61
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med (2004) 3.55
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood (2007) 3.52
PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res (2013) 3.48
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell (2011) 3.47
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest (2004) 3.47
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells. Cancer Cell (2010) 3.46
Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev (2007) 3.45
Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). Nat Biotechnol (2008) 3.43
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw (2007) 3.40
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature (2011) 3.37
Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell (2012) 3.36
Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med (2005) 3.35
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood (2005) 3.32
Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol (2003) 3.30
Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol (2002) 3.29
Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev (2005) 3.27
Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J Leukoc Biol (2006) 3.21
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell (2008) 3.15
Myc-induced T cell leukemia in transgenic zebrafish. Science (2003) 3.15
The use of zebrafish to understand immunity. Immunity (2004) 3.09
Activating Notch1 mutations in mouse models of T-ALL. Blood (2005) 3.08
B cell receptor signal strength determines B cell fate. Nat Immunol (2004) 3.06
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood (2009) 3.02
Mitoferrin is essential for erythroid iron assimilation. Nature (2006) 2.99
SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol Cell (2002) 2.93